GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction
GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction. // Biological Psychiatry Global Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2667174326001060?dgcid=rss_sd_all
GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction. Biological Psychiatry Global Open Science. https://www.sciencedirect.com/science/article/pii/S2667174326001060?dgcid=rss_sd_all
“GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.” Biological Psychiatry Global Open Science.
@article{article37992,
title = {GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction},
journal = {Biological Psychiatry Global Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2667174326001060?dgcid=rss_sd_all}
}